Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device ...

As modern sound therapy gains entry among the healing methods that complement the therapies, it achieves acknowledgment in the contemporary practices of therapy. Singing bowls and gongs—previously ...

Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world's first investigational drug for large-area subcutaneous fat reduction developed under the 505(b)(1) ...

Abbreviated breast MRI shortens exam time while retaining a high level of diagnostic accuracy of breast cancer in women with extremely dense breasts, according to an article published today in ...

Black patients admitted to the hospital for labor and delivery are more likely to have stigmatizing language documented in their clinical notes than White patients, Columbia University School of ...

"Liquid biopsy is a revolutionary, non-invasive method for detecting diseases like cancer through blood samples instead of traditional tissue biopsies. This market is rapidly growing, offering ...

The EIC Soft-landing Programme provides business development support and opportunities to connect with investors, academic institutions and life science stakeholders in Boston – a global hub for ...

Taking care of our family and loved ones throughout their lives is a key facet of human connection. However, there may come a time, whether due to disease, age, or other inevitability, they could ...

Abbreviated breast MRI shortens exam time while retaining a high level of diagnostic accuracy of breast cancer in women with extremely dense breasts, according to an article published today in… ...

This multicenter, randomized study, sponsored by Philips will enroll 824 coronary artery disease patients across 6 hospitals in Spain, Czech Republic and the US. The first patient in the study was ...

Submission based on positive data from two pivotal studies, which both met their primary endpoints. U.S. clearance expected in Q3 2025 based on average observed review timelines for radiological ...

When high-performing executives face substance use disorders or mental health challenges, the stakes extend beyond personal well-being to encompass professional legacies, organizational ...